Remnant cholesterol and new-onset atrial fibrillation: The Atherosclerosis Risk in Communities study

Xiaolan Ouyang1, Xixiang Tang2, Long Peng1

  • 1Department of Cardiovascular Medicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Heart Rhythm
|October 21, 2024
PubMed

Insights

Higher remnant cholesterol (RC) levels, especially baseline and variable RC, increase the risk of developing atrial fibrillation (AF). This study clarifies the link between RC characteristics and new-onset AF.

Area of Science:

  • Cardiovascular Medicine
  • Epidemiology
  • Biochemistry

Background:

  • The association between remnant cholesterol (RC) and atrial fibrillation (AF) requires further investigation.
  • Understanding this relationship is crucial for predicting and preventing AF.

Purpose of the Study:

  • To comprehensively explore the association between various remnant cholesterol (RC) characteristics and the incidence of new-onset atrial fibrillation (AF).

Main Methods:

  • Analysis of data from the Atherosclerosis Risk in Communities (ARIC) study across five follow-up visits.
  • Multidimensional evaluation of RC including baseline level, variability, cumulative exposure, and trajectory.
  • Cox proportional hazards analyses to assess the relationship between RC characteristics and AF incidence in two cohorts.

Main Results:

  • Elevated baseline RC and RC variability were significantly associated with an increased risk of new-onset AF.
  • The highest quartile of baseline RC showed a hazard ratio of 1.16 (P=.039), and RC variability showed 1.30 (P<.001).
  • Cumulative RC and high-increasing RC trajectory indicated a trend toward heightened AF risk, though not statistically significant.

Conclusions:

  • Higher remnant cholesterol (RC) levels, particularly baseline levels and variability, are linked to an increased risk of developing atrial fibrillation (AF).
  • These findings highlight RC as a potential risk factor for AF.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
1
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1
Atherosclerosis II: Clinical manifestations and prevention01:27

Atherosclerosis II: Clinical manifestations and prevention

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
1
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
517
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
135
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3